Analysis of the Influence of the Exposome in Patients With Non-communicable Diseases
EXPOSOME
EXPOSOME
Sponsor study identifier
observational
2,500
1 country
1
Study Start
October 30, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
October 30, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
October 30, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
It is well documented that factors such as obesity, a sedentary lifestyle, and comorbidities-including hypertension, diabetes, and dyslipidemia-increase the risk of developing non-communicable diseases (NCDs). However, few studies have evaluated the influence of the exposome, which encompasses both internal and external factors. While existing literature examines isolated factors, research integrating both dimensions remains scarce. Assessing exposome components enables a better understanding of the complex interplay between the environment, lifestyle, and health status. This study aims to provide mechanistic insight into the impact of exposomic factors-such as climatic variations, lifestyle behaviors, and pollution-on NCDs.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 30, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 10, 2026
Actual (reported)October 16, 2026
Actual (reported)October 30, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
October 30, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
October 30, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Association of non-communicable diseases with exposures.
Association of non-communicable diseases (e.g., cardiovascular diseases, type 2 diabetes, chronic respiratory diseases) with exposures, in addition to an assessment based on exposure levels (dose-response analysis).
one day
Interview with patient for 30 minutes with questions about his medical history, his mental health and his lifestyle, on his housing, regarding the characteristics of his workplace.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patient aged 40 or older receiving outpatient or inpatient care at RAMSAY SANTE hospitals.
Hôpital privé Paul d'Egine
Champigny-sur-Marne, 94500, France
First Submitted
October 10, 2026
First Posted
October 16, 2026
Study Start
October 30, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
October 30, 2027
EstimatedImpact of Endotest on Patients' Quality of Life: a Cohort Study
Primitive Immunodeficiency, Intrauterine Devices and Menstrual Hygiene Products
Contact the study team to confirm eligibility.
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
October 30, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
October 16, 2026
Record last verified: 2026-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: